Assessing CorMedix (CRMD) Valuation After Recent Momentum Pause and Melinta Therapeutics Acquisition [Yahoo! Finance]
CorMedix Inc. (CRMD)
NASDAQ:AMEX Investor Relations:
cormedix.com
Company Research
Source: Yahoo! Finance
Investors are now weighing its year-to-date climb of 31% in comparison to its recent one month pause. See our latest analysis for CorMedix. CorMedix's momentum has slowed a bit after its strong climb earlier this year, with the share price largely holding steady over the past month. Even so, the stock is up 31% year-to-date, standing in sharp contrast to its 10.6% drop in total shareholder return over the last twelve months. While some are waiting to see if the recent pause signals caution, its remarkable 182% total return over three years still highlights significant long-term growth potential that can be difficult to overlook. If you're watching biotech names for the next wave of opportunity, now is a good time to broaden your scope and discover See the full list for free. With CorMedix still trading well below analyst price targets and fundamentals showing solid growth, investors may wonder if the stock is underappreciated or if future gains are already fully reflected in t
Show less
Read more
Impact Snapshot
Event Time:
CRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRMD alerts
High impacting CorMedix Inc. news events
Weekly update
A roundup of the hottest topics
CRMD
News
- Assessing CorMedix (CRMD): Is the Current Share Price Reflecting Its True Value? [Yahoo! Finance]Yahoo! Finance
- Cormedix Inc (CRMD) Q3 2025 Earnings Call Highlights: Record Financial Performance and ... [Yahoo! Finance]Yahoo! Finance
- Does the Recent 9.9% Pullback Make CorMedix a Bargain in 2025? [Yahoo! Finance]Yahoo! Finance
- Buy Rating Reaffirmed: CorMedix Inc. (CRMD) Posts Profitability and Expands Outlook for 2025 [Yahoo! Finance]Yahoo! Finance
- H.C. Wainwright Raises the PT on ?CorMedix Inc. (CRMD), Keeps a Buy [Yahoo! Finance]Yahoo! Finance
CRMD
Earnings
- 11/12/25 - Beat
CRMD
Sec Filings
- 12/4/25 - Form 4
- 12/1/25 - Form SCHEDULE
- 11/26/25 - Form 4
- CRMD's page on the SEC website